Research Publications

Prednisone withdrawal followed by interferon alpha for treatment of chronic hepatitis C infection: results of a randomized controlled trial.

McHutchison JG, Ponnudurai R, Bylund DL, Anguiano A, Pockros PJ, Mondala T, Wilkes LB

An open-label pilot trial of cladibrine (2-cholordeoxyadenosine) in patients with primary sclerosing cholangitis.

Duchini A, Younossi ZM, Saven A, Bordin GM, Knowles HJ, Pockros PJ

LKM-positive autoimmune hepatitis in the western United States: a case series.

Duchini A, McHutchison JG, Pockros PJ

Influenza infection in patients before and after liver transplantation.

Duchini A, Hendry RM, Redfield DC, Pockros PJ

Pulmonary infarction after liver transplant and previous hepatopulmonary syndrome.

Duchini A, Bradley S, Russack V, Pockros PJ

Hepatic decompensation in patients with cirrhosis during infection with influenza A.

Duchini A, Viernes ME, Nyberg LM, Hendry RM, Pockros PJ

Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group.

Reddy KR, Hoofnagle JH, Tong MJ, Lee WM, Pockros P, Heathcote EJ, Albert D, Joh T

A comparison of reverse transcription-polymerase chain reaction and branched-chain DNA assays for hepatitis C virus RNA in patients receiving interferon treatment. Consensus Interferon Study Group.

Pockros PJ, Bain VG, Hunter EB, Conrad A, Balart A, Hollinger FB, Albert D

Mastocytosis: diverse presentations and outcomes.

Pauls JD, Brems J, Pockros PJ, Saven A, Wagner RL, Weber R, Metcalfe D, Christiansen SC

Relationship between biochemical and virological responses to interferon therapy in chronic hepatitis C infection. Consensus Interferon Study Group.

Pockros PJ, Tong M, Lee WM, van Leeuwen DJ, Keeffe EB, Bala K, Killenberg PG, Foust RT, Rosenblate HJ, Payne KM, Fromm H, Lesesne HR, Black M